What’s new? Keep track of Evomet’s progress on the News page!
Evomet is an Innovative Training Network (ITN) with a mission to train Early Stage Researchers in metastasis progression.
Evomet comprises several of the best academic, clinical and industrial entities in cancer and metastasis research in Europe.
Evomet leverages basic research on the evolution of metastatic cancers to impact drug development and the clinical standard of care.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 955951